Pay in 4 interest-free payments of $7.40 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
After 15 years of compounding peptides for patientsBPC-157 for inflammatory bowel disease, CJC-1295 for growth hormone deficiencythe FDA had just added his two highest-volume compounds to their Category 2 list
Every compound is independently third-party tested, with a lot-matched Certificate of Analysis (COA) and a GHS-format Safety Data Sheet (SDS) available for download
Each lot is characterized before release so your assays start from a known baseline
The pharmacy pleaded guilty to distributing unapproved drugs including BPC-157 across state lines, resulting in a $1.79 million forfeiture. Their interstate sales transformed a potential state regulatory issue into a federal criminal case
